|
1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation, and apoptosis: A review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar
|
|
4
|
Worsham MJ, Ali H, Dragovic J and
Schweitzer VP: Molecular characterization of head and neck cancer:
How close to personalized targeted therapy? Mol Diagn Ther.
16:209–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar
|
|
6
|
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY,
Wu KJ, Chiou SH, Lin SC and Chang KW: miR-31 ablates expression of
the HIF regulatory factor FIH to activate the HIF pathway in head
and neck carcinoma. Cancer Res. 70:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kinoshita T, Hanazawa T, Nohata N, Kikkawa
N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto
Y, et al: Tumor suppressive microRNA-218 inhibits cancer cell
migration and invasion through targeting laminin-332 in head and
neck squamous cell carcinoma. Oncotarget. 3:1386–1400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Bhayani MK, Dodge CT, Nicoloso MS,
Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, et al:
Coordinated targeting of the EGFR signaling axis by microRNA-27a*.
Oncotarget. 4:1388–1398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y and
Zhou LF: The miR-92b functions as a potential oncogene by targeting
on Smad3 in glioblastomas. Brain Res. 1529:16–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Q, Shen K, Zhao Y, Ma C, Liu J and Ma
J: MiR-92b inhibitor promoted glioma cell apoptosis via targeting
DKK3 and blocking the Wnt/beta-catenin signaling pathway. J Transl
Med. 11:3022013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shah AA, Leidinger P, Blin N and Meese E:
miRNA: Small molecules as potential novel biomarkers in cancer.
Curr Med Chem. 17:4427–4432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng F, Glaser SS, Francis H, DeMorrow S,
Han Y, Passarini JD, Stokes A, Cleary JP, Liu X, Venter J, et al:
Functional analysis of microRNAs in human hepatocellular cancer
stem cells. J Cell Mol Med. 16:160–173. 2012. View Article : Google Scholar
|
|
13
|
Nass D, Rosenwald S, Meiri E, Gilad S,
Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A,
Kharenko O, et al: MiR-92b and miR-9/9* are specifically expressed
in brain primary tumors and can be used to differentiate primary
from metastatic brain tumors. Brain Pathol. 19:375–383. 2009.
View Article : Google Scholar :
|
|
14
|
Haug BH, Henriksen JR, Buechner J, Geerts
D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B
and Einvik C: MYCN-regulated miRNA-92 inhibits secretion of the
tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Carcinogenesis. 32:1005–1012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Li L, Guan Y, Liu X, Meng Q and Guo
Q: MiR-92b regulates the cell growth, cisplatin chemosensitivity of
A549 non small cell lung cancer cell line and target PTEN. Biochem
Biophys Res Commun. 440:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu
P, Song Z, Qian C, Chen Y, Yang S, et al: miR-92b controls glioma
proliferation and invasion through regulating Wnt/beta-catenin
signaling via Nemo-like kinase. Neuro Oncol. 15:578–588. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allen CT, Ricker JL, Chen Z and Van Waes
C: Role of activated nuclear factor-kappaB in the pathogenesis and
therapy of squamous cell carcinoma of the head and neck. Head Neck.
29:959–971. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhave SL, Teknos TN and Pan Q: Molecular
parameters of head and neck cancer metastasis. Crit Rev Eukaryot
Gene Expr. 21:143–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Z and Li Y, Takwi A, Li B, Zhang J,
Conklin DJ, Young KH, Martin R and Li Y: miR-301a as an NF-κB
activator in pancreatic cancer cells. EMBO J. 30:57–67. 2011.
View Article : Google Scholar :
|
|
20
|
Jiang L, Lin C, Song L, Wu J, Chen B, Ying
Z, Fang L, Yan X, He M, Li J, et al: MicroRNA-30e* promotes human
glioma cell invasiveness in an orthotopic xenotransplantation model
by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest.
122:33–47. 2012. View
Article : Google Scholar :
|
|
21
|
Ding J, Huang S, Wang Y, Tian Q, Zha R,
Shi H, Wang Q, Ge C, Chen T, Zhao Y, et al: Genome-wide screening
reveals that miR-195 targets the TNF-α/NF-κB pathway by
down-regulating IκB kinase alpha and TAB3 in hepatocellular
carcinoma. Hepatology. 58:654–666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katoh M and Katoh M: Transcriptional
mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and
Notch signaling cascades. Int J Mol Med. 23:763–769. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yasuda J, Yokoo H, Yamada T, Kitabayashi
I, Sekiya T and Ichikawa H: Nemo-like kinase suppresses a wide
range of transcription factors, including nuclear factor-kappaB.
Cancer Sci. 95:52–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li SZ, Zhang HH, Liang JB, Song Y, Jin BX,
Xing NN, Fan GC, Du RL and Zhang XD: Nemo-like kinase (NLK)
negatively regulates NF-kappa B activity through disrupting the
interaction of TAK1 with IKKβ. Biochim Biophys Acta.
1843:1365–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
